Parker Hannifin Indego Exoskeleton Receives FDA Clearance From: Robotics Trends - 03/10/2016 By: Steve Crowe Parker Hannifin said it will commercially launch Indego in the US in the coming months. The powered exoskeleton is already commercially available in Europe, having received the CE Mark in November 2015. The Food and Drug Administration (FDA) has given Parker Hannifin permission to market and sell its Indego exoskeleton for clinical and personal use in the United States. More than 270,000 patients with severe spinal cord injuries in the US now have options when it comes to exoskeleton use. Prior to Indego receiving FDA clearance, ReWalk was the only FDA-cleared exoskeleton for both rehabilitation and personal use in the US. Read the entire article and view a video (2:57) at: http://www.roboticstrends.com/article/parker_hannifin_indego_exoskeleton_receives_fda_clearance Links: FDA Clears Indego Exoskeleton for Clinical and Personal Use http://www.mdtmag.com/news/2016/03/fda-clears-indego-exoskeleton-clinical-and-personal-use Parker Hannifin http://www.roboticstrends.com/company/parker_hannifin Indego http://www.indego.com/indego/en/home Parker Hannifin Indego Exoskeleton http://www.roboticstrends.com/article/parker_hannifin_indego_exoskeleton ReWalk Exoskeleton Reluctantly Covered by Insurance Companies http://www.roboticstrends.com/article/rewalk_exoskeleton_reluctantly_covered_by_insurance_co/Exoskeleton Talking Exoskeletons with suitX Founder Dr. Homayoon Kazerooni http://www.roboticstrends.com/article/talking_exoskeletons_with_suitx_founder_dr_homayoon_kazerooni/Exoskeleton